ASH 2022 Conference Coverage
ASH 2022 Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial ADVANCE IV: Efficacy & Safety of IV Efgartigimod in Adults With Primary ITP
By
ASH 2022 Conference Coverage
FEATURING
Catherine Broome
By
ASH 2022 Conference Coverage
FEATURING
Catherine Broome
Login to view comments.
Click here to Login